The European Medicines Agency is planning to hold two workshops in September to support ongoing efforts to develop guidance on the impact of the EU General Data Protection Regulation (GDPR) on the secondary use of health data to support the development, evaluation and supervision of medicines.
The first workshop, to be held on 23 September, will be a virtual event where patients and consumers as...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?